Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rona Beegan"'
Autor:
Pedro Mb Rodrigues, Marcin Mankowski, Salman Siddiqui, Angela Thompson, Ratko Djukanovic, Davinder Dosanjh, Najib M. Rahman, Richard J Marsden, Victoria Tear, Sandra Aitken, Toby N Batten, Jody Brookes, Alastair Watson, Tristan W Clark, Tom Wilkinson, Dave Singh, Sophie Hemmings, Lorcan McGarvey, Michael G. Crooks, Phillip Monk, Felicity J Gabbay, Stephen T. Holgate, Tim Harrison, Edmund Foster, Donna E. Davies, Adam Fleet, Ling-Pei Ho, Alex Horsley, Sarah Dudley, Dinesh Saralaya, Rona Beegan, Jacklyn A Smith
Publikováno v:
The Lancet Respiratory Medicine
Monk, P D, Marsden, R J, Tear, V J, Brookes, J, Batten, T N, Mankowski, M, Gabbay, F J, Davies, D E, Holgate, S T, Ho, L-P, Clark, T, Djukanovic, R, Wilkinson, T M A & Group, I I B COVID S 2021, ' Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial ', The Lancet. Respiratory medicine, vol. 9, no. 2, pp. 196—206 . https://doi.org/10.1016/s2213-2600(20)30511-7
Monk, P D, Marsden, R J, Tear, V J, Brookes, J, Batten, T N, Mankowski, M, Gabbay, F J, Davies, D E, Holgate, S T, Ho, L-P, Clark, T, Djukanovic, R, Wilkinson, T M A & Group, I I B COVID S 2021, ' Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial ', The Lancet. Respiratory medicine, vol. 9, no. 2, pp. 196—206 . https://doi.org/10.1016/s2213-2600(20)30511-7
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries a substantial risk of severe and prolonged illness; treatment options are currently limited. We assessed the efficacy and safety of inhaled nebulised interferon
Publikováno v:
Airway pharmacology and treatment.
Background: Interferon beta (IFN-β) plays a key role in host defence against viruses, triggering the expression of interferon stimulated genes (ISG) which restrict viral replication and promote antiviral immune responses. Inhaled IFN-β is being dev
Autor:
Phillip Monk, Rachel Pestridge, Jonathan Macintyre, James Roberts, Ajerico del Rosario, Chang Xiao, Sebastian L. Johnston, Rona Beegan, Peter Adura, Tatiana Kebadze, Eleanor Reed, Christine B. Boxall, James E. Gern, Victoria Cornelius, Ratko Djukanovic, Juliya Aniscenko
Publikováno v:
European Respiratory Journal
To the Editor : The majority of asthma exacerbations are associated with respiratory virus infections, mostly rhinoviruses (RVs) [1], due to enhanced inflammation in the airways [2]. These occur despite symptom control with inhaled corticosteroids (I
Autor:
Rona Beegan, Wolfgang Jarolimek, Phillip Monk, Donna E. Davies, Sumeet Mahajan, Victoria Tear, Mark Jones, Kerry Lunn, James Roberts, Tual Monfort, Lucy Cao
Publikováno v:
QJM: An International Journal of Medicine.
Introduction: The lung tissue of patients with idiopathic pulmonary fibrosis (IPF) is characterised by dense collections of myofibroblasts and extracellular matrix (ECM) termed ‘fibroblastic foci’. Using a novel in vitro model of fibroblastic foc
Autor:
Paul Rucki, Peter Adura, Chang Xiao, Valia Kehagia, Joanna Samways, Ratko Djukanovic, Phillip Monk, Lara Balls, Chrissy Boxall, Rona Beegan
Publikováno v:
D21. MICROBIAL CONTRIBUTIONS TO ASTHMA PATHOGENESIS.
Autor:
Rona Beegan, Phillip Monk, Christine B. Boxall, Rachel Pestridge, Peter Adura, Chang Xiao, James Roberts, Ratko Djukanovic, Pawel Rucki
Publikováno v:
A38. MICROBIAL INFLUENCES ON ASTHMA AND COPD.
Publikováno v:
B14. NOVEL TREATMENTS FOR LUNG INFECTIONS: MODULATING IMMUNE RESPONSES.
Autor:
Cathy Xiao, Donna E. Davies, Christine B. Boxall, Joel Haywood, Phillip Monk, Rona Beegan, Stephen T. Holgate
Publikováno v:
D54. PNEUMONIA: BENCH TO BEDSIDE.
Autor:
Rona Beegan, Rachel Pestridge, T Kabadze, Jerico Del Rosario, Jonathan Macintyre, Peter Adura, Sebastian L. Johnston, Christine B. Boxall, Phillip Monk, Eleanor Reed, James Roberts, James E. Gern, Ratko Djukanovic
Publikováno v:
D13. VIRUS-HOST INTERACTIONS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.